-
-
-
-
-
-
-
UPDATE: Jefferies Downgrades Menlo Therapeutics (MNLO) to Hold Citing Surprising Serlopitant Ph2 AD Miss
-
-
-
-
-
-
-
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
-
72,076 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

